Vaccination to Reduce Antimicrobial Resistance Burden—Data Gaps and Future Research
Clinical Infectious Diseases · 20.12.2023 · 77 (Supplement_7) · S597-S607
DOI: 10.1093/cid/ciad562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.12.2023. Verfasst von Birkneh Tilahun Tadesse und 11 weiteren Autor:innen. Beteiligte Einrichtung: International Vaccine Institute, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Vaccines. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance (AMR) poses an immediate danger to global health. If unaddressed, the current upsurge in AMR threatens to reverse the achievements in reducing the infectious disease–associated mortality and morbidity associated with antimicrobial treatment. Consequently, there is an urgent need for strategies to prevent or slow the progress of AMR. Vaccines potentially contribute both directly and indirectly to combating AMR. Modeling studies have indicated significant gains from vaccination in reducing AMR burdens for specific pathogens, reducing mortality/morbidity, and economic loss. However, quantifying the real impact of vaccines in these reductions is challenging because many of the study designs used to evaluate the contribution of vaccination programs are affected by significant background confounding, and potential selection and information bias. Here, we discuss challenges in assessing vaccine impact to reduce AMR burdens and suggest potential approaches for vaccine impact evaluation nested in vaccine trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Vaccine Institute, Seoul, Republic of Korea.
- Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Independent Consultant, Johannesburg, South Africa.
- Wellcome Sanger Institute and Microbiotica, Cambridge, United Kingdom.
- Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
ORCID-Profile: Birkneh Tilahun Tadesse
Zitieren
APA
Tadesse, B. T., Keddy, K. H., Rickett, N. Y., Zhusupbekova, A., Poudyal, N., Lawley, T., Osman, M., Dougan, G., Kim, J. H., Lee, J. S., Jeon, H. J., & Marks, F. (2023). Vaccination to Reduce Antimicrobial Resistance Burden—Data Gaps and Future Research. Clinical Infectious Diseases, 77(Supplement_7), S597-S607. https://doi.org/10.1093/cid/ciad562
Vancouver
Tadesse BT, Keddy KH, Rickett NY, Zhusupbekova A, Poudyal N, Lawley T, et al. Vaccination to Reduce Antimicrobial Resistance Burden—Data Gaps and Future Research. Clinical Infectious Diseases. 2023;77(Supplement_7):S597-S607. doi:10.1093/cid/ciad562
BibTeX
@article{Tadesse2023,
author = {Tadesse, Birkneh Tilahun and Keddy, Karen H and Rickett, Natasha Y and Zhusupbekova, Aidai and Poudyal, Nimesh and Lawley, Trevor and Osman, Majdi and Dougan, Gordon and Kim, Jerome H and Lee, Jung-Seok and Jeon, Hyon Jin and Marks, Florian},
title = {Vaccination to Reduce Antimicrobial Resistance Burden—Data Gaps and Future Research},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {Supplement_7},
pages = {S597--S607},
doi = {10.1093/cid/ciad562}
}
EUVIMED